Association of glutamate carboxypeptidase II (GCPII) haplotypes with breast and prostate cancer risk

Gene

Volumn 516, Issue 1, 2013, Pages 76-81

  Divyya, Shree ^a   Naushad, Shaik Mohammad ^a   Addlagatta, Anthony ^b   Murthy, P V L N ^a   Reddy, Ch Ram ^a   Digumarti, Raghunadha Rao ^a   Gottumukkala, Suryanarayana Raju ^a   Subbarao, Sreedhar Amere ^c   Kutala, Vijay Kumar ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

^b INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^c CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Breast cancer; Folate hydrolase; Glutamate carboxypeptidase II; Haplotype; Prostate cancer; Prostate specific membrane antigen

Indexed keywords

FOLIC ACID; GLUTAMATE CARBOXYPEPTIDASE II;

ADULT; AGED; ARTICLE; BINDING SITE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CATALYSIS; CELL STRAIN LNCAP; CONTROLLED STUDY; DIETARY INTAKE; DISEASE SEVERITY; ENZYME ACTIVITY; EX VIVO STUDY; FAMILY HISTORY; FEMALE; FOLIC ACID BLOOD LEVEL; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

ADULT; AGED; ANTIGENS, SURFACE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTAMATE CARBOXYPEPTIDASE II; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; PROTEIN CONFORMATION; RISK FACTORS; YOUNG ADULT;

EID: 84873095561     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.11.047     Document Type: Article

References (36)

1. Afman L.A., Trijbels F.J., Blom H.J. The H475Y polymorphism in the glutamate carboxypeptidase II gene increases plasma folate without affecting the risk for neural tube defects in humans. J. Nutr. 2003, 133:75-77.
2. Banerjee S.R., Pullambhatla M., Shallal H., et al. A modular strategy to prepare multivalent inhibitors of prostate-specific membrane antigen (PSMA). Oncotarget 2011, 2(12):244-253.
3. Barinka C., Mlcochová P., Sácha P., et al. Amino acids at the N- and C-termini of human glutamate carboxypeptidase II are required for enzymatic activity and proper folding. Eur. J. Biochem. 2004, 271:2782-2790.
4. Barinka C., Hlouchova K., Rovenska M., et al. Structural basis of interactions between human glutamate carboxypeptidase II and its substrate analogs. J. Mol. Biol. 2008, 376:1438-1450.
5. Baslow M.H. The astrocyte surface NAAG receptor and NAAG peptidase signaling complex as a therapeutic target. Drug News Perspect. 2008, 21:251-257.
6. Chang S.S., O'Keefe D.S., Bacich D.J., et al. Prostate-specific membrane antigen is produced in tumor-associated neovasculature. Clin. Cancer Res. 1999, 5:2674-2681.
7. Chen J., Kyte C., Valcin M., et al. Polymorphisms in the one-carbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective study. Int. J. Cancer 2004, 1;110(4):617-620.
8. Collin S.M., Metcalfe C., Zuccolo L., et al. Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis. Cancer Epidemiol. Biomarkers Prev. 2009, 8:2528-2539.
9. Collin S.M., Metcalfe C., Refsum H., et al. Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer. Cancer Epidemiol. Biomarkers Prev. 2010, 19(11):2833-2838.
10. Collin S.M., Metcalfe C., Refsum H., et al. Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiol. Biomarkers Prev. 2010, 19(6):1632-1642.
11. Divyya S., Naushad S.M., Addlagatta A., et al. Paradoxical role of H475Y glutamate carboxypeptidase II (GCPII) genetic polymorphism in altering disease susceptibility. Gene 2012, 497(2):273-279.
12. Duthie S.J., Narayanan S., Brand G.M., et al. Impact of folate deficiency on DNA stability. J. Nutr. 2002, 132(8 Suppl.):2444S-2449S.
13. Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D: Biol. Crystallogr. 2004, 60(Pt. 12 Pt. 1):2126-2132.
14. Födinger M., Dierkes J., Skoupy S., et al. Effect of glutamate carboxypeptidase II and reduced folate carrier polymorphisms on folate and total homocysteine concentrations in dialysis patients. J. Am. Soc. Nephrol. 2003, 14:1314-1319.
15. Ghadge G.D., Slusher B.S., Bodner A., et al. Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:9554-9559.
16. Halsted C.H., Ling E.H., Luthi-Carter R., et al. Folylpoly-gamma-glutamate carboxypeptidase from pig jejunum: molecular characterization and relation to glutamate carboxypeptidase II. J. Biol. Chem. 1998, 273:20417-20424.
17. Halsted C.H., Wong D.H., Peerson J.M., et al. Relations of glutamate carboxypeptidase II (GCPII) polymorphisms to folate and homocysteine concentrations and to scores of cognition, anxiety, and depression in a homogeneous Norwegian population: the Hordaland Homocysteine Study. Am. J. Clin. Nutr. 2007, 86:514-521.
18. Krebs J. McCance and Widdowson's The Composition of Foods: Summary Edition 2002, The Royal Society of Chemistry/Food Standards Agency, Cambridge/London. 6th summary ed.
19. Lopreato F.R., Stabler S.P., Carvalho F.R., et al. Relationships between gene polymorphisms of folate-related proteins and vitamins and metabolites in pregnant women and neonates. Clin. Chim. Acta 2008, 398:134-139.
20. Luthi-Carter R., Barczak A.K., Speno H., Coyle J.T. Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase). J. Pharmacol. Exp. Ther. 1998, 286:1020-1025.
21. Mlcochová P., Barinka C., Tykvart J., et al. Prostate-specific membrane antigen and its truncated form PSM'. Prostate 2009, 69:471-479.
22. Morin I., et al. Evaluation of genetic variants in the reduced folate carrier and in glutamate carboxypeptidase II for spina bifida risk. Mol. Genet. Metab. 2003, 79:197-200.
23. Naushad S.M., Reddy C.A., Rupasree Y., et al. Cross-talk between one-carbon metabolism and xenobiotic metabolism: implications on oxidative DNA damage and susceptibility to breast cancer. Cell Biochem. Biophys. 2011, 61:715-723.
24. Naushad S.M., Pavani A., Digumarti R.R., et al. Epistatic interactions between loci of one-carbon metabolism modulate susceptibility to breast cancer. Mol. Biol. Rep. 2011, 38:4893-4901.
25. Naushad S.M., Prayaga A., Digumarti R.R., et al. Bcl-2/adenovirus E1B 19kDa-interacting protein 3 (BNIP3) expression is epigenetically regulated by one-carbon metabolism in invasive duct cell carcinoma of breast. Mol. Cell. Biochem. 2012, 361:189-195.
26. Naushad S.M., Pavani A., Rupasree Y., et al. Association of aberrations in one-carbon metabolism with molecular phenotype and grade of breast cancer. Mol. Carcinog 2012, 51(Suppl 1):E32-E41. (Oct).
27. Petersen, L.F., Brockton, N.T., Bakkar, A., et al., in press. Elevated physiological levels of folic acid can increase in vitro growth and invasiveness of prostate cancer cells. BJU Int. 109 (5), 788-95.
28. Rawlings N.D., Barrett A.J. Structure of membrane glutamate carboxypeptidase. Biochim. Biophys. Acta 1997, 1339:247-252.
29. Roffman J.L., Brohawn D.G., Nitenson A.Z., et al. Genetic variation throughout the folate metabolic pathway influences negative symptom severity in Schizophrenia. Schizophr. Bull. 2011, [Epub ahead of print] PMID: 22021659.
30. Sambrook J., Fitsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual 1989, Cold Spring Harbor Press, Cold Spring Harbor.
31. Samplaski M.K., Heston W., Elson P., et al. Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature. Mod. Pathol. 2011, 24:1521-1529.
32. U.S. Department of Agriculture., Agricultural Research Service USDA National Nutrient Database for Standard Reference, Release 18 Nutrient Data Laboratory Home Page. http://www.ars.usda.gov/ba/bhnrc/ndl.
33. Warren L.D. The PyMOL Molecular Graphics System. DeLano Scientific LLC, San Carlos, CA, USA http://www.pymol.org.
34. Winkelmayer W.C., Eberle C., Sunder-Plassmann G., Födinger M. Effects of the glutamate carboxypeptidase II (GCPII 1561C>T) and reduced folate carrier (RFC1 80G>A) allelic variants on folate and total homocysteine levels in kidney transplant patients. Kidney Int. 2003, 63:2280-2285.
35. Wright G.L., Haley C., Beckett M.L., Schellhammer P.F. Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues. Urol. Oncol. 1995, 1:18-28.
36. Yao V., Parwani A., Maier C., et al. Moderate expression of prostate-specific membrane antigen, a tissue differentiation antigen and folate hydrolase, facilitates prostate carcinogenesis. Cancer Res. 2008, 68:9070-9077.